Computed tomography (CT) is a diagnostic device that is used as imaging tool that helps in diagnosing diseases, abnormality, and trauma. These scanners create various images in the form of 3D images, 2D images, and Cross sectional images, which study the internal injuries, complicated tissues or abnormalities, which help in taking early prevention measures to avoid further health risk. The major advantage of computed tomography is its ability to image bone, blood vessels, and soft tissue at the same time. The increasing prevalence of diseases in population across the globe is driving market towards developing accurate and efficient diagnostic tools which can help in detection of abnormalities from early stages too. Technological development in diagnostic tools can help to decrease the mortality rate in chronic diseases such as cancer, heart disease, and others.
Global Computed Tomography Market - Impact of the Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic is expected to drive the growth of the global computed tomography market over the forecast period. The Coronavirus (COVID- 19) has had a major impact on healthcare system worldwide. It affected the diagnostic imaging centers as during pandemic it was observed that several non-urgent treatments were kept on hold to provide extra attention towards COVID-19 patients. Various countries’ government officials announced medical emergencies and allowed for urgent medical services for Covid -19 patients. For instance, on March 19, 2020, the Ontario government issued Directive #2, which included the requirement to reduced or eliminate all non-essential and elective service to bare minimum.
During the COVID-19 pandemic, various symptoms such as respiratory issues were observed in patients as it is a highly transmissible acute respiratory disease which is caused by severe acute respiratory syndrome (SARS). Chest CT has a major role in the diagnosis and detection of complications caused by coronavirus disease. This is expected to increase the growth of the computed tomography market over the forecast period. For instance, a study published by The Radiological Society of North America (RSNA) on October 23, 2020, regarding Chest CT in COVID-19 indicates that several chest CT images indicated common symptoms in COVID-19 patients, which included ground-glass opacities, bilateral abnormalities, posterior predilection, vascular enlargement, and lower lobe involvement. This procedure helped in providing urgent medications to patients to avoid the spread of infection in the chest
Increasing awareness regarding diagnostic ways by CT in various diseases plays an important role in the market. This helps with the availability of funding sources for research and development of advanced technological devices. For instance, the National Institute of Biomedical Imaging and Bioengineering (NIBIB) is funding a breast CT scanner that will allow 3D imaged pictures for the diagnosis of tumours responsible for breast cancer. This funding is basically raised for the development of devices that will help to decrease the amount of radiation used in CT scans.
The global computed tomography market is estimated to be valued at US$ 7,101.7 Mn in 2021 and is expected to exhibit a CAGR of 6.1% over the forecast period (2021-2028).
Figure 1. Global Computed Tomography Market Share (%), Analysis, By Application, 2021
Increasing research and development activities by the market players for developing the technologically advanced computed tomography devices is expected to drive the growth over the forecast period.
Market players are involved in research and development activities for developing the technologically advanced CT devices. This is expected to increase the growth of the market over the forecast period. For instance, on September 30, 2021, the United States Food and Drug Administration (U.S. FDA) released news regarding clearance for Siemens NAEOTOM Alpha developed by Siemens Medical Solutions Inc. a company which provides medical instruments and equipment. The FDA followed 510(k) premarket clearance pathway for reviewing the Siemens NAEOTOM Alpha. A 510(k) is a premarket submission made by companies to FDA to demonstrate device developed by company is effective and safe, and equivalent to a legally marketed devices.
Market players are indulged in receiving approvals for the CT systems indicated for the diagnosis of various diseases. This is expected to increase the growth of the global computed tomography market over the forecast period.
Increasing approvals from the regulatory authorities are expected to increase the growth of the market over the forecast period. For instance, on December 01, 2020, the U.S. FDA approved Ga 68 PSMA-11 for Positron emission tomography (PET), which was developed for patients with suspected prostate cancer metastasis. Ga 68 PSMA-11 is a radioactive diagnostic agent. Moreover, in the U.S., prostate cancer is the third most common form of cancer.
Computed Tomography Market Report Coverage
||Market Size in 2021:
||US$ 7,101.7 Mn
|Historical Data for:
||2018 to 2020
||2021 to 2028
|Forecast Period 2021 to 2028 CAGR:
||2028 Value Projection:
||US$ 10,750.0 Mn
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
- By Types: Stationary CT Scanners, Portable CT Scanners
- By Application: Human Application, Diagnostic Applications, Cardiology Applications, Oncology Applications, Neurology Applications, Other Diagnostic Applications, Intraoperative Applications, Veterinary Application, Research Application
- By End User: Hospital and Research Centers, Diagnostic Imaging Centers
United Medical Imaging Inc., Siemens Healthineers, Canon Medical Systems Corporations, GE Healthcare, Hitachi Healthcare Americas, Koninklijke Philips N.V., NeuroLogica Corporation, Neusoft Medical Systems Co. Ltd., Shenzhen Anke High-Tech Co. Ltd., Eaton, Hologic, Arineta, Analogic, Samsung, Carestream Health, and Toshiba
- Increasing product approvals
- Increasing research and development activities
|Restraints & Challenges:
- Increased use of CT scans exposes people to more radiation
Global Computed Tomography Market – Restraints
The increasing use of CT devices with direct exposure to radiation may lead to cancer. For instance, an article published in hospital healthcare Europe shows a survey by a team from the department of Diagnostic and Interventional Radiology, University of Pisa, Italy states that the use of imaging techniques has increased over the past few years as a diagnostic aid , although the concerns have been raised by clinicians, especially among the pediatrics population, that tremendously used devices such as computed tomography (CT), have increased exposure to radiation. Moreover, there is evidence that the overall cancer incidence was 24% higher in those who were exposed to radiations by CT scan, especially among individuals aged under 19 years of age.
For patients with a regular clinical routine, advanced CT scans can cost as much as basic scans. For instance, study published in new choice health indicates that in the U.S. average cost of a CT scan is US$ 3,275. The cost of the CT imaging procedure may differ as per the disease diagnostic requirements for patients. This procedure can be costly for non-insurance-holder patients.
Global Computed Tomography Market – Regional Analysis
On the basis of region, the global computed tomography market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold a dominant position in global computed tomography market during forecast period, owing to the increasing market for diagnostic uses of CT. For instance, on September 22, 2021, United Imagining, a global leader in advanced medical imaging and radiotherapy equipment, announced U.S.FDA clearance for uCT ATLAS. The uCT ATLAS has features like Z-Detector architecture, workflow innovations, and low dose capabilities.
Furthermore, Europe region is expected to anticipate the second largest market after North America in global computed tomography market, owing to the development in advanced devices as per market requirement by following rules and guidelines issued by the FDA. For instance, on September 30, 2021, the U.S. FDA approved the Siemens Naeotom Alpha, a photon counting computed tomography system scanner through the 510(k) premarket clearance pathway. Siemens Healthineers AG is medical technology company based in Germany. Naeotom Alpha is developed with the new diagnostic imaging system which utilizes CT technology of photon counting detectors for measuring the X-ray passed through patient’s body and converts them into a detailed three dimensional (3D) image.
Figure 2: Global Computed Tomography Market (US$ Mn), by Region, 2021
Global Computed Tomography Market – Competitive Landscape
Major players operating in the global computed tomography market include United Medical Imaging Inc., Siemens Healthineers, Canon Medical Systems Corporations, GE Healthcare, Hitachi Healthcare Americas, Koninklijke Philips N.V., NeuroLogica Corporation, Neusoft Medical Systems Co. Ltd., Shenzhen Anke High-Tech Co. Ltd., Toshiba, Carestream Health, Eaton, Samsung, Hologic, Arineta, and Analogic.